Zuzanna Fimińska
Zuzanna Fimińska
Latest posts from :
Even though erectile dysfunction affects to some degree over half of all men...
Although the future of pharma might be in services, the industry has to change...
It is a truth universally acknowledged that in this tough payer climate, pharma...
To overcome its image problem with the public, pharma must open all channels of...
The permanent method of contraception for women continues to cause controversy,...
The rules governing reimbursement and market access for new products are...
Providing “beyond the pill” patient solutions requires new organizational...
As pharma faces transition from traditional business model to a value-based...
Latin America provides pharma with a unique opportunity to get involved with...
Clinical trials as we know it are over. Their annual cost is unsustainable and...